EPIX Pharmaceuticals Inc (EPIX)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

4 MAGUIRE ROAD LEXINGTON, MA 02421

Epix Pharma discovers and develops pharmaceuticals for imaging that are designed to transform the diagnosis, treatment and monitoring of disease. The company is developing two products for use in MRI to improve the diagnosis of multiple diseases involving the vascular system): Vasovist; and EP-2104R.

Are you looking for this stock instead?

View SEC Filings from EPIX instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding EPIX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EPIX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PRESCOTT GROUP CAPITAL MANAGEMENT LLC

FROHLICH PHIL

  • 10% Owner
10,567,556 2009-07-21 0

DRAPKIN KIMBERLEE C CHIEF FINANCIAL OFFICER

  • Officer
324,367 2009-06-30 0

PHELPS GREGORY D

  • Director
0 2009-06-16 0

FRANK FRED

  • Director
0 2009-06-16 0

GILMAN MICHAEL

  • Director
0 2009-06-16 0

LEUCHTENBERGER MARK

  • Director
0 2009-06-16 0

SMITH IAN F

  • Director
0 2009-06-16 0

GAMZU ELKAN R PRESIDENT AND CEO

  • Officer
  • Director
0 2009-04-30 0

SCHOR CHEN CHIEF BUSINESS OFFICER

  • Officer
146,235 2009-02-25 0

PEREZ ROBERT J

  • Director
0 2008-05-19 0

KAUFFMAN MICHAEL G CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2008-02-25 0

UPRICHARD ANDREW C G PRESIDENT

  • Officer
0 2008-02-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments